Chronic lymphocytic leukemia (CLL) of B-cell type in remission is a hematological malignancy characterized by the accumulation of functionally incompetent B-lymphocytes. This condition is clinically significant as it requires ongoing monitoring and management to prevent relapse. The ICD-10 Code C91.11 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
What is ICD-10 Code C91.11 for Chronic lymphocytic leukemia of B-cell type in remission?
ICD-10 Code C91.11 represents Chronic lymphocytic leukemia of B-cell type in remission, indicating that the disease is currently not active. This code is used when documenting patients who have previously been diagnosed with CLL and are now in a state of remission, allowing for appropriate clinical documentation and billing practices.
ICD-10 Code C91.11 – Clinical Definition and Explanation of Chronic lymphocytic leukemia of B-cell type in remission
Chronic lymphocytic leukemia of B-cell type in remission is a condition where the malignant B-lymphocytes are no longer proliferating or causing symptoms. This state is crucial as it indicates a response to treatment and requires careful monitoring to prevent relapse. Medical attention is necessary to manage potential complications and ensure ongoing patient health.
Key Clinical Features:
- Presence of elevated lymphocyte counts in blood tests.
- Absence of symptoms such as fatigue, weight loss, or night sweats.
- Regular follow-up appointments to monitor for signs of relapse.
- Potential for secondary complications, including infections.
ICD-10 Code C91.11 for Chronic lymphocytic leukemia of B-cell type in remission – SOAP Notes & Clinical Use
ICD-10 Code C91.11 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring that healthcare providers accurately capture the patient's clinical status and treatment needs.
What Does ICD-10 Code C91.11 for Chronic lymphocytic leukemia of B-cell type in remission Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C91.11 connects subjective patient reports and objective clinical findings to a formal diagnosis of CLL in remission. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C91.11 – Chronic lymphocytic leukemia of B-cell type in remission
Management of Chronic lymphocytic leukemia of B-cell type in remission focuses on monitoring and supportive care to maintain remission and prevent complications.
Antibiotic Therapy:
- Not typically indicated unless there is an infection; consider prophylactic antibiotics in high-risk patients.
Supportive Care:
- Regular monitoring of blood counts and overall health.
- Management of any symptoms or complications.
- Patient education on signs of relapse.
Infection Control:
- Encourage good hygiene practices.
- Vaccination against preventable infections as appropriate.
- Monitor for signs of infection, especially in immunocompromised patients.
How to Document Symptoms of Chronic lymphocytic leukemia of B-cell type in remission (ICD-10 C91.11) in SOAP Notes
Subjective:
- Patient reports feeling well with no new symptoms.
- Denies fatigue, weight loss, or night sweats.
- History of previous treatment for CLL.
Objective:
- Complete blood count shows stable lymphocyte levels.
- Physical examination reveals no lymphadenopathy or splenomegaly.
- Vital signs within normal limits.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Chronic lymphocytic leukemia of B-cell type in remission (ICD-10 Code C91.11)
Assessment:
- Chronic lymphocytic leukemia of B-cell type in remission, stable condition.
- ICD-10 Code: C91.11.
- No current symptoms or complications noted.
Plan:
- Continue regular follow-up appointments every 3-6 months.
- Monitor blood counts and overall health.
- Educate patient on signs of potential relapse.
Treatment & Plan Section for ICD-10 Code C91.11 – Chronic lymphocytic leukemia of B-cell type in remission
- Regular monitoring of blood counts and clinical status.
- Patient education on recognizing symptoms of relapse.
- Supportive care as needed for any complications.
- Follow-up appointments scheduled for ongoing assessment.
Using ICD-10 Code C91.11 for Chronic lymphocytic leukemia of B-cell type in remission in Billing & SOAP Note Compliance
- Ensure accurate documentation of patient history and current status.
- Use C91.11 in appropriate clinical settings to support billing.
- Document any relevant symptoms or treatment changes clearly.
- Align treatment plans with clinical guidelines for justified billing.
Related ICD-10 Codes Often Used with Chronic lymphocytic leukemia of B-cell type in remission
- C91.10 – Chronic lymphocytic leukemia of B-cell type, unspecified
- C91.12 – Chronic lymphocytic leukemia of B-cell type, active
ICD-10 Code C91.11 in Medical Billing and Insurance for Chronic lymphocytic leukemia of B-cell type in remission
ICD-10 Code C91.11 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Document all relevant patient history and treatment details.
- Use C91.11 in conjunction with other codes as necessary.
- Ensure compliance with coding guidelines to support claims.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C91.11 for Chronic lymphocytic leukemia of B-cell type in remission
What does it mean to be in remission from Chronic lymphocytic leukemia?
Being in remission means that the signs and symptoms of Chronic lymphocytic leukemia are not currently present, and the disease is not actively progressing. Regular monitoring is essential to ensure that the condition remains stable.
How often should patients with CLL in remission be monitored?
Patients in remission should typically have follow-up appointments every 3 to 6 months, including blood tests to monitor lymphocyte levels and overall health.
Can Chronic lymphocytic leukemia come back after remission?
Yes, Chronic lymphocytic leukemia can relapse after a period of remission. Continuous monitoring and patient education on symptoms of relapse are crucial for early detection.
What are the common treatments for Chronic lymphocytic leukemia?
Treatment options may include chemotherapy, targeted therapy, and immunotherapy. The specific approach depends on the individual patient's condition and response to previous treatments.
